尽管收益超过并更新了每股收益指引，但Owens & Minor的股票还是创下了52周的低点。 Owens & Minor's stock hits a 52-week low despite beating earnings and updating EPS guidance.

医疗保健解决方案提供商Owens & Minor在几个研究公司降低了价格目标后,创下了52周新低的10.74美元. Owens & Minor, a healthcare solutions provider, hit a new 52-week low of $10.74 after several research firms reduced their price targets. 尽管预期收益为每股0.42美元,而且报告收入为27.2亿美元,但股票面临分析师降级,现在市场上限为7.4226亿美元。 Despite beating earnings expectations at $0.42 per share and reporting $2.72 billion in revenue, the stock faced analyst downgrades and now has a market cap of $742.26 million. 该公司还更新了其Q4 2024 EPS指南,将其更新为0.520-0.550,与分析师的估计十分一致。 The company also updated its Q4 2024 EPS guidance to 0.520-0.550, aligning closely with analyst estimates.